Study of the Antiviral Efficacy and Safety of Atazanavir in Combination with Ritonavir or Saquinavir and the Combination of Lopinavir/Ritonavir Each With Tenofovir and Nucleoside in Subjects who Have Experienced Virologic Failure

Grants and Contracts Details

StatusFinished
Effective start/end date11/1/0112/31/08

Funding

  • Bristol Myers Squibb Company: $31,663.00